Bristol-Myers Squibb to Split Off Mead Johnson Holdings
Bristol-Myers Squibb Co. is splitting off its holdings in Enfamil infant formula maker Mead Johnson Nutrition Co., in order to focus on its biopharmaceutical business, particulary development of new biotechnology medecines. For each $1 of Bristol-Myers stock swapped, shareholders will get about $1.11 worth of Mead shares. The shares have risen 89 percent in the […]